167 related articles for article (PubMed ID: 15325242)
1. Structural and functional analysis of the Josephin domain of the polyglutamine protein ataxin-3.
Chow MK; Mackay JP; Whisstock JC; Scanlon MJ; Bottomley SP
Biochem Biophys Res Commun; 2004 Sep; 322(2):387-94. PubMed ID: 15325242
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the structure and the amyloidogenic properties of the Josephin domain of the polyglutamine-containing protein ataxin-3.
Masino L; Nicastro G; Menon RP; Dal Piaz F; Calder L; Pastore A
J Mol Biol; 2004 Dec; 344(4):1021-35. PubMed ID: 15544810
[TBL] [Abstract][Full Text] [Related]
3. Flanking domain stability modulates the aggregation kinetics of a polyglutamine disease protein.
Saunders HM; Gilis D; Rooman M; Dehouck Y; Robertson AL; Bottomley SP
Protein Sci; 2011 Oct; 20(10):1675-81. PubMed ID: 21780213
[TBL] [Abstract][Full Text] [Related]
4. Functional interactions as a survival strategy against abnormal aggregation.
Masino L; Nicastro G; Calder L; Vendruscolo M; Pastore A
FASEB J; 2011 Jan; 25(1):45-54. PubMed ID: 20810784
[TBL] [Abstract][Full Text] [Related]
5. Deubiquitinating function of ataxin-3: insights from the solution structure of the Josephin domain.
Mao Y; Senic-Matuglia F; Di Fiore PP; Polo S; Hodsdon ME; De Camilli P
Proc Natl Acad Sci U S A; 2005 Sep; 102(36):12700-5. PubMed ID: 16118278
[TBL] [Abstract][Full Text] [Related]
6. Mode of substrate recognition by the Josephin domain of ataxin-3, which has an endo-type deubiquitinase activity.
Satoh T; Sumiyoshi A; Yagi-Utsumi M; Sakata E; Sasakawa H; Kurimoto E; Yamaguchi Y; Li W; Joazeiro CA; Hirokawa T; Kato K
FEBS Lett; 2014 Nov; 588(23):4422-30. PubMed ID: 25448680
[TBL] [Abstract][Full Text] [Related]
7. Ataxin-3 with an altered conformation that exposes the polyglutamine domain is associated with the nuclear matrix.
Perez MK; Paulson HL; Pittman RN
Hum Mol Genet; 1999 Dec; 8(13):2377-85. PubMed ID: 10556285
[TBL] [Abstract][Full Text] [Related]
8. Understanding the role of the Josephin domain in the PolyUb binding and cleavage properties of ataxin-3.
Nicastro G; Todi SV; Karaca E; Bonvin AM; Paulson HL; Pastore A
PLoS One; 2010 Aug; 5(8):e12430. PubMed ID: 20865150
[TBL] [Abstract][Full Text] [Related]
9. Crystal structure of a Josephin-ubiquitin complex: evolutionary restraints on ataxin-3 deubiquitinating activity.
Weeks SD; Grasty KC; Hernandez-Cuebas L; Loll PJ
J Biol Chem; 2011 Feb; 286(6):4555-65. PubMed ID: 21118805
[TBL] [Abstract][Full Text] [Related]
10. Caspase-mediated proteolysis of the polyglutamine disease protein ataxin-3.
Berke SJ; Schmied FA; Brunt ER; Ellerby LM; Paulson HL
J Neurochem; 2004 May; 89(4):908-18. PubMed ID: 15140190
[TBL] [Abstract][Full Text] [Related]
11. Ataxin-3 suppresses polyglutamine neurodegeneration in Drosophila by a ubiquitin-associated mechanism.
Warrick JM; Morabito LM; Bilen J; Gordesky-Gold B; Faust LZ; Paulson HL; Bonini NM
Mol Cell; 2005 Apr; 18(1):37-48. PubMed ID: 15808507
[TBL] [Abstract][Full Text] [Related]
12. Poly-ubiquitin binding by the polyglutamine disease protein ataxin-3 links its normal function to protein surveillance pathways.
Chai Y; Berke SS; Cohen RE; Paulson HL
J Biol Chem; 2004 Jan; 279(5):3605-11. PubMed ID: 14602712
[TBL] [Abstract][Full Text] [Related]
13. Josephin domain of ataxin-3 contains two distinct ubiquitin-binding sites.
Nicastro G; Masino L; Esposito V; Menon RP; De Simone A; Fraternali F; Pastore A
Biopolymers; 2009 Dec; 91(12):1203-14. PubMed ID: 19382171
[TBL] [Abstract][Full Text] [Related]
14. The solution structure of the Josephin domain of ataxin-3: structural determinants for molecular recognition.
Nicastro G; Menon RP; Masino L; Knowles PP; McDonald NQ; Pastore A
Proc Natl Acad Sci U S A; 2005 Jul; 102(30):10493-8. PubMed ID: 16020535
[TBL] [Abstract][Full Text] [Related]
15. Mouse models of Machado-Joseph disease and other polyglutamine spinocerebellar ataxias.
Colomer Gould VF
NeuroRx; 2005 Jul; 2(3):480-3. PubMed ID: 16389311
[TBL] [Abstract][Full Text] [Related]
16. Towards a structural understanding of the fibrillization pathway in Machado-Joseph's disease: trapping early oligomers of non-expanded ataxin-3.
Gales L; Cortes L; Almeida C; Melo CV; Costa MC; Maciel P; Clarke DT; Damas AM; Macedo-Ribeiro S
J Mol Biol; 2005 Oct; 353(3):642-54. PubMed ID: 16194547
[TBL] [Abstract][Full Text] [Related]
17. Conserved domains and lack of evidence for polyglutamine length polymorphism in the chicken homolog of the Machado-Joseph disease gene product ataxin-3.
Linhartová I; Repitz M; Dráber P; Nemec M; Wiche G; Propst F
Biochim Biophys Acta; 1999 Feb; 1444(2):299-305. PubMed ID: 10023088
[TBL] [Abstract][Full Text] [Related]
18. Identification and functional dissection of localization signals within ataxin-3.
Antony PM; Mäntele S; Mollenkopf P; Boy J; Kehlenbach RH; Riess O; Schmidt T
Neurobiol Dis; 2009 Nov; 36(2):280-92. PubMed ID: 19660550
[TBL] [Abstract][Full Text] [Related]
19. Structural and functional analysis of ataxin-2 and ataxin-3.
Albrecht M; Golatta M; Wüllner U; Lengauer T
Eur J Biochem; 2004 Aug; 271(15):3155-70. PubMed ID: 15265035
[TBL] [Abstract][Full Text] [Related]
20. Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70.
Warrick JM; Chan HY; Gray-Board GL; Chai Y; Paulson HL; Bonini NM
Nat Genet; 1999 Dec; 23(4):425-8. PubMed ID: 10581028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
